Utility of the Cerebral Organoid Glioma ‘GLICO’ Model for Screening Applications

Glioblastoma, a grade IV astrocytoma, is regarded as the most aggressive primary brain tumour with an overall median survival of 16.0 months following the standard treatment regimen of surgical resection, followed by radiotherapy and chemotherapy with temozolomide. Despite such intensive treatment,...

Descripción completa

Detalles Bibliográficos
Autores principales: Weth, Freya R., Peng, Lifeng, Paterson, Erin, Tan, Swee T., Gray, Clint
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818141/
https://www.ncbi.nlm.nih.gov/pubmed/36611949
http://dx.doi.org/10.3390/cells12010153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818141/
https://www.ncbi.nlm.nih.gov/pubmed/36611949
http://dx.doi.org/10.3390/cells12010153

Ejemplares similares